MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...
Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care The transaction supports Hologic’s strategy to provide a comprehensive suite of ...
Rising incidence of breast cancer, growing adoption of breast-conserving surgeries, and increasing demand for minimally invasive and radiation-free localization technologies are the major factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results